Brief: Novabay Pharmaceuticals Entered First Amendment To That Certain Services Agreement With TLF Bio Innovation Lab
Sept 10 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS INC - ENTERED FIRST AMENDMENT TO
THAT
CERTAIN SERVICES AGREEMENT WITH TLF BIO INNOVATION LAB
* NOVABAY PHARMACEUTICALS INC - AGREED TO AMEND CERTAIN
PROVISIONS
OF AGREEMENT PRIMARILY RELATED TO EQUITY AWARDS, AND RELATED
MILESTONES
* NOVABAY PHARMACEUTICALS INC - TLF BIO INNOVATION WILL BE
ELIGIBLE FOR WARRANTS EXERCISABLE FOR UP TO 2 MILLION SHARES
Source: (https://bit.ly/33jTI5b)
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing